Amylyx outlines Phase 3 LUCIDITY trial design for avexitide in post-bariatric hypoglycemia at ENDO 2026

Amylyx

Amylyx

AMLX

0.00
  • Amylyx Pharmaceuticals announced two poster presentations scheduled for ENDO 2026 in Chicago on June 13-16, 2026.
  • Data will be presented in the future, not previously disclosed results.
  • One poster will outline the US burden of post-bariatric hypoglycemia, highlighting healthcare use, economic impact, and quality-of-life effects.
  • A second poster will cover patient-informed design choices for the Phase 3 LUCIDITY trial of avexitide, a GLP-1 receptor antagonist.
  • The update signals continued late-stage development work in post-bariatric hypoglycemia, with trial execution and disease burden framing as near-term focus areas.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Amylyx Pharmaceuticals Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260608097177) on June 08, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.